Recent Finacing
Recent Raise
Clarametyx Biosciences is a clinical-stage biotech in Columbus developing pathogen-agnostic, immune-enabling biologics and vaccines that target biofilm matrix to collapse biofilms, including antibody CMTX-101 (Phase 1b/2a) and vaccine CMTX-301.
